S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 4, 2011, Pages

  Hopson, Kristen Park ^a   Truelove, Jessica ^a   Chun, Jerold ^b   Wang, Yumei ^a   Waeber, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Blood vessels; Sphingosine 1 phosphate; Sphingosine 1 phosphate receptor; Stim1

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STROMAL INTERACTION MOLECULE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BRAIN ARTERY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FLUORESCENCE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STORE OPERATED CALCIUM ENTRY; TRANSPORT KINETICS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; BORON COMPOUNDS; CALCIUM; CELLS, CULTURED; GENE EXPRESSION; LYSOPHOSPHOLIPIDS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, LYSOSPHINGOLIPID; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPHINGOSINE; VASOCONSTRICTION;

EID: 79955151636     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00350.2010     Document Type: Article

References (59)

1. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103: 1289-1299, 2008.
2. Anliker B, Chun J. Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol 15: 457-465, 2004.
3. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 295: C779-C790, 2008.
4. Bootman MD, Berridge MJ, Roderick HL. Calcium signalling: more messengers, more channels, more complexity. Curr Biol 12: R563-R565, 2002.
5. 2+ stores and on electrostatic interactions. Mol Biol Cell 20: 389-399, 2009.
6. Coussin F, Scott RH, Wise A, Nixon GF. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 91: 151-157, 2002.
7. Daum G, Grabski A, Reidy MA. Sphingosine 1-phosphate: a regulator of arterial lesions. Arterioscler Thromb Vasc Biol 29: 1439-1443, 2009.
8. David KC, Scott RH, Nixon GF. Advanced glycation endproducts induce a proliferative response in vascular smooth muscle cells via altered calcium signaling. Biochem Pharmacol 76: 1110-1120, 2008.
9. DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW Jr. Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 283: 19265-19273, 2008.
10. Derler I, Fritsch R, Schindl R, Romanin C. CRAC inhibitors: identification and potential. Expert Opin Drug Discov 3: 787-800, 2008.
11. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146: 62-68, 2003.
12. Fellner SK, Arendshorst WJ. Store-operated Ca2+ entry is exaggerated n fresh preglomerular vascular smooth muscle cells of SHR. Kidney Int 61: 2132-2141, 2002.
13. Flemming R, Xu SZ, Beech DJ. Pharmacological profile of storeoperated channels in cerebral arteriolar smooth muscle cells. Br J Pharmacol 139: 955-965, 2003.
14. Giachini FR, Chiao CW, Carneiro FS, Lima VV, Carneiro ZN, Dorrance AM, Tostes RC, Webb RC. Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: a novel insight into vascular dysfunction. Hypertension 53: 409-416, 2009.
15. Grabski AD, Shimizu T, Deou J, Mahoney WM Jr, Reidy MA, Daum G. Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. Arterioscler Thromb Vasc Biol 29: 1644-1650, 2009.
16. Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharm Res 47: 401-407, 2003.
17. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJ, Kingsbury MA, Yang AH, Zhang G, Brown JH, Chun J. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3. J Biol Chem 277: 25152-25159, 2002.
18. Kono M, Belyantseva IA, Skoura A, Frolenkov GI, Starost MF, Dreier JL, Lidington D, Bolz SS, Friedman TB, Hla T, Proia RL. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282: 10690-10696, 2007.
19. Lefkimmiatis K, Srikanthan M, Maiellaro I, Moyer MP, Curci S, Hofer AM. Store-operated cyclic AMP signalling mediated by STIM1. Nat Cell Biol 11: 433-442, 2009.
20. Leung FP, Yung LM, Yao X, Laher I, Huang Y. Store-operated calcium entry in vascular smooth muscle. Br J Pharmacol 153: 846-857, 2008.
21. 2+ influx. Curr Biol 15: 1235-1241, 2005.
22. Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ. Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 292: R440-R446, 2007.
23. 2+ in vascular smooth muscle: effects on CREB activation. Br J Pharmacol 147: 351-359, 2006.
24. 2+ mobilization independently of G-protein-coupled receptors. FEBS Lett 554: 443-449, 2003.
25. Michel MC, Mulders AC, Jongsma M, Alewijnse AE, Peters SL. Vascular effects of sphingolipids. Acta Paediatr Suppl 96: 44-48, 2007.
26. Muik M, Fahrner M, Derler I, Schindl R, Bergsmann J, Frischauf I, Groschner K, Romanin C. A cytosolic homomerization and a modulatory domain within STIM1 C terminus determine coupling to ORAI1 channels. J Biol Chem 284: 8421-8426, 2009.
27. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376.
28. Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, Takeda S, Hasegawa T, Sasamori J, Konno T, Hayashi K, Watanabe Y, Mori K, Sato Y, Takahashi A, Mochizuki N, Takakura N. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol Pharmacol 77: 704-713, 2010.
29. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, Ozaki Y. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 58: 170-177, 2003.
30. 2+ influx and constriction in cerebral, mesenteric, and carotid arteries. Am J Physiol Heart Circ Physiol 294: H1183-H1187, 2008.
31. Peter BF, Lidington D, Harada A, Bolz HJ, Vogel L, Heximer S, Spiegel S, Pohl U, Bolz SS. Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res 103: 315-324, 2008.
32. Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA, Trebak M. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 23: 2425-2437, 2009.
33. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230-233, 2006.
34. 2+ source-dependent transcription of CRE-containing genes in vascular smooth muscle. Am J Physiol Heart Circ Physiol 291: H97-H105, 2006.
35. Pulver RA, Rose-Curtis P, Roe MW, Wellman GC, Lounsbury KM. Store-operated Ca2+ entry activates the CREB transcription factor in vascular smooth muscle. Circ Res 94: 1351-1358, 2004.
36. Putney JW. Capacitative calcium entry: from concept to molecules. Immunol Rev 231: 10-22, 2009.
37. Putney JW Jr. Pharmacology of capacitative calcium entry. Mol Interv 1: 84-94, 2001.
38. Qiao L, Kozikowski AP, Olivera A, Spiegel S. Synthesis and evaluation of a photolyzable derivative of sphingosine 1-phosphate- caged SPP. Bioorg Med Chem Lett 8: 711-714, 1998.
39. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15: 100-108, 2007.
40. Rodat-Despoix L, Aires V, Ducret T, Marthan R, Savineau JP, Rousseau E, Guibert C. Signalling pathways involved in the contractile response to 5-HT in the human pulmonary artery. Eur Respir J 34: 1338-1347, 2009.
41. Ross K, Whitaker M, Reynolds NJ. Agonist-induced calcium entry correlates with STIM1 translocation. J Cell Physiol 211: 569-576, 2007.
42. Salomone S, Potts EM, Tyndall S, Ip PC, Chun J, Brinkmann V, Waeber C. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 153: 140-147, 2008.
43. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, Moskowitz MA, Waeber C. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 469: 125-134, 2003.
44. Spiegel S, Merrill AH Jr. Sphingolipid metabolism and cell growth regulation. FASEB J 10: 1388-1397, 1996.
45. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003.
46. Takahashi Y, Watanabe H, Murakami M, Ono K, Munehisa Y, Koyama T, Nobori K, Iijima T, Ito H. Functional role of stromal interaction molecule 1 (STIM1) in vascular smooth muscle cells. Biochem Biophys Res Commun 361: 934-940, 2007.
47. Tamarina NA, Kuznetsov A, Philipson LH. Reversible translocation of EYFP-tagged STIM1 is coupled to calcium influx in insulin secreting beta-cells. Cell Calcium 44: 533-544, 2008.
48. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T, Kimura T, Sasaki T. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 32: 2913-2919, 2001.
49. Varnai P, Hunyady L, Balla T. STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 30: 118-128, 2009.
50. Waeber C, Blondeau N, Salomone S. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. Drug News Perspect 17: 365-382, 2004.
51. Wamhoff BR, Lynch KR, Macdonald TL, Owens GK. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 28: 1454-1461, 2008.
52. 2+ entry in adenosine-induced vasodilatation of rat small mesenteric artery. Am J Physiol Heart Circ Physiol 297: H347-H354, 2009.
53. Watterson KR, Ratz PH, Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal 17: 289-298, 2005.
54. Yang AH, Ishii I, Chun J. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim Biophys Acta 1582: 197-203, 2002.
55. 2+ influx. Mol Pharmacol 66: 702-707, 2004.
56. 2+ and inhibition by polycations. Br J Pharmacol 138: 234-244, 2003.
57. Zbidi H, Lopez JJ, Amor NB, Bartegi A, Salido GM, Rosado JA. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol Dis 43: 211-213, 2009.
58. +-induced constriction: role for SOCs in small arteries. Am J Physiol Heart Circ Physiol 283: H2692-H2705, 2002.
59. 2+ channel activity of human Orai1 and Orai3. J Biol Chem 283: 17662-17671, 2008.